Testing a sleep medicine for children with insomnia
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This study tests if the drug tasimelteon helps children with insomnia sleep better compared to a placebo (a pill with no medicine). It is for children aged 2 to 17 who have been diagnosed with insomnia that is not caused by another medicine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 2 and 17 years old
- You have been diagnosed with insomnia by a doctor
- Your sleep problem is not caused by another medication you are taking
- You have not had a bad reaction to tasimelteon before
- Your liver is working normally
- If you are female and able to have children, you are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational medication to help people with insomnia fall asleep faster and stay asleep longer. If you have trouble sleeping despite trying other treatments, this trial may offer a new option.
This study compares how well different over-the-counter and prescription sleep medications work for insomnia. Researchers will guide you through trying medications one at a time to find what works best for your sleep problems.
This study tests whether melatonin can help teens (ages 13–17) who have trouble sleeping. You may be able to join if you’ve never taken melatonin before and your sleep issue seems to be behavior-related rather than caused by another medical sleep problem.
This trial tests a new inhaled form of melatonin to help adults aged 55 and older with insomnia fall asleep faster. It compares the inhaled melatonin to a placebo to see if it improves sleep and is safe.
This study tests a new sleep medication called tasimelteon compared to a placebo (inactive treatment) for people with a specific sleep disorder linked to a genetic change in the body's internal clock. If you have Delayed Sleep-Wake Phase Disorder and carry the CRY1Δ11 variant, this trial may help improve your sleep timing.
This study tests a sleep medication called ramelteon for people with chronic insomnia. If you qualify, you may receive the study drug or a placebo, and researchers will monitor your sleep over several weeks to see if it helps you fall asleep faster and sleep longer.
Hear when a new Insomnia Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.